US Bancorp’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19 | Hold |
17
| – | – | ﹤0.01% | 4131 |
|
2025
Q1 | $20 | Sell |
17
-9
| -35% | -$11 | ﹤0.01% | 4149 |
|
2024
Q4 | $159 | Sell |
26
-64
| -71% | -$391 | ﹤0.01% | 4088 |
|
2024
Q3 | $1.49K | Buy |
90
+73
| +429% | +$1.21K | ﹤0.01% | 3820 |
|
2024
Q2 | $117 | Hold |
17
| – | – | ﹤0.01% | 3903 |
|
2024
Q1 | $164 | Hold |
17
| – | – | ﹤0.01% | 3903 |
|
2023
Q4 | $141 | Hold |
17
| – | – | ﹤0.01% | 3896 |
|
2023
Q3 | $142 | Sell |
17
-381
| -96% | -$3.18K | ﹤0.01% | 3899 |
|
2023
Q2 | $3.67K | Buy |
398
+117
| +42% | +$1.08K | ﹤0.01% | 3530 |
|
2023
Q1 | $3.86K | Sell |
281
-151
| -35% | -$2.08K | ﹤0.01% | 3594 |
|
2022
Q4 | $7.35K | Sell |
432
-1,034
| -71% | -$17.6K | ﹤0.01% | 3380 |
|
2022
Q3 | $34K | Sell |
1,466
-68
| -4% | -$1.58K | ﹤0.01% | 2747 |
|
2022
Q2 | $28K | Sell |
1,534
-903
| -37% | -$16.5K | ﹤0.01% | 2868 |
|
2022
Q1 | $65K | Buy |
2,437
+2,093
| +608% | +$55.8K | ﹤0.01% | 2480 |
|
2021
Q4 | $10K | Sell |
344
-3,130
| -90% | -$91K | ﹤0.01% | 3400 |
|
2021
Q3 | $229K | Sell |
3,474
-2,375
| -41% | -$157K | ﹤0.01% | 1908 |
|
2021
Q2 | $486K | Sell |
5,849
-72
| -1% | -$5.98K | ﹤0.01% | 1563 |
|
2021
Q1 | $454K | Buy |
5,921
+2,791
| +89% | +$214K | ﹤0.01% | 1551 |
|
2020
Q4 | $276K | Sell |
3,130
-2,962
| -49% | -$261K | ﹤0.01% | 1729 |
|
2020
Q3 | $449K | Buy |
6,092
+5,779
| +1,846% | +$426K | ﹤0.01% | 1380 |
|
2020
Q2 | $23K | Buy |
+313
| New | +$23K | ﹤0.01% | 2701 |
|